PT - JOURNAL ARTICLE AU - SHINTARO SHIBA AU - NORIYUKI OKONOGI AU - SHINGO KATO AU - MASARU WAKATSUKI AU - DAIJIRO KOBAYASHI AU - HIROKI KIYOHARA AU - TATSUYA OHNO AU - KUMIKO KARASAWA AU - TAKASHI NAKANO AU - TADASHI KAMADA TI - Clinical Impact of Re-irradiation with Carbon-ion Radiotherapy for Lymph Node Recurrence of Gynecological Cancers DP - 2017 Oct 01 TA - Anticancer Research PG - 5577--5583 VI - 37 IP - 10 4099 - http://ar.iiarjournals.org/content/37/10/5577.short 4100 - http://ar.iiarjournals.org/content/37/10/5577.full SO - Anticancer Res2017 Oct 01; 37 AB - Background/Aim: To evaluate the safety and efficacy of re-irradiation with carbon-ion radiotherapy (C-ion RT) for lymph node recurrence of gynecological cancers after definitive radiotherapy. Patients and Methods: Data regarding patients with unresectable and isolated recurrent lymph node from gynecological cancer after definitive radiotherapy were analyzed. Total dose of C-ion RT was 48-57.6 Gy (RBE) in 12 or 16 fractions. Results: Sixteen patients received re-irradiation by C-ion RT were analyzed. Median follow-up was 37 months. Median tumor size was 27 mm. None developed Grade 1 or higher acute toxicities and Grade 3 or higher late toxicities. The 3-year overall survival, local control and disease-free survival rates after C-ion RT were 74%, 94% and 55%, respectively. Conclusion: Re-irradiation with C-ion RT for lymph node recurrence of gynecological cancers after definitive radiotherapy can be safe and effective. This result suggested that C-ion RT could be a curative treatment option for conventionally difficult-to-cure patients.